Lentivirus Infections
Showing 1 - 25 of 7,089
HIV Coinfection, Aids/Hiv Problem, Tuberculosis, Pulmonary Trial in Saint Petersburg (Interferon-Gamma)
Completed
- HIV Coinfection
- +5 more
-
Saint Petersburg, Saint-Petersburg, Russian Federation
- +1 more
Sep 23, 2021
Solid and Hematological Malignancies Trial in United States (Axicabtagene Ciloleucel, Brexucabtagene Autoleucel, KITE-585)
Enrolling by invitation
- Solid and Hematological Malignancies
- Axicabtagene Ciloleucel
- Brexucabtagene Autoleucel (KTE-X19)
-
Duarte, California
- +7 more
Jun 29, 2022
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
Rejection; Transplant, Liver, Liver Failure, Liver Diseases Trial in Cambridge, London (QEL-001)
Recruiting
- Rejection; Transplant, Liver
- +2 more
-
Birmingham, United Kingdom
- +3 more
Dec 22, 2022
Non Hodgkin Lymphoma Trial in Cleveland (UF-KURE19 CAR-T cells, Fludarabine, Cyclophosphamide)
Recruiting
- Non Hodgkin Lymphoma
- UF-KURE19 CAR-T cells
- +2 more
-
Cleveland, Ohio
- +1 more
Nov 21, 2022
HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)
Suspended
- HIV Infections
- BG505 MD39.3 mRNA
- +2 more
-
Birmingham, Alabama
- +9 more
Feb 1, 2023
Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T
Recruiting
- Non Hodgkin Lymphoma
- +2 more
- Fully human anti CD19 CAR-T Cell Dose
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Oct 4, 2022
HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))
Enrolling by invitation
- HIV
- Antiretroviral Therapy Interruption(ATI)
-
Washington, District of Columbia
- +1 more
Sep 12, 2022
Adenosine Deaminase Severe Combined Immune Deficiency Trial (A cryopreserved formulation of autologous mPB CD34+ hematopoietic
Not yet recruiting
- Adenosine Deaminase Severe Combined Immune Deficiency
- A cryopreserved formulation of autologous mPB CD34+ hematopoietic stem and progenitor cells transduced ex vivo with the EFS-ADA lentiviral vector encoding the human ADA enzyme
- (no location specified)
Jun 20, 2022
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program Trial in Worldwide
Recruiting
- Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
- Previously treated CAR-T patients
-
Phoenix, Arizona
- +71 more
Nov 14, 2022
Wiskott-Aldrich Syndrome (WAS) Trial in Milan (OTL-103)
Active, not recruiting
- Wiskott-Aldrich Syndrome (WAS)
- OTL-103
-
Milan, ItalyOspedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Apr 21, 2022
Acute Lymphoid Leukemia Trial in Spain (ARI-0001 cells)
Recruiting
- Acute Lymphoid Leukemia
- ARI-0001 cells
-
Badalona, Barcelona, Spain
- +9 more
Feb 3, 2022
X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Suspended
- X-linked Severe Combined Immunodeficiency (XSCID)
- Palifermin
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Subjects Exposed to Genetically Engineered T Cell Receptors
Terminated
- Solid and Hematological Malignancies
- Genetically engineered T Cell Receptors
-
Nashville, Tennessee
- +2 more
Jan 5, 2021
Sinusitis, Otitis, Laryngitis Trial in Ljubljana (Treatment with surgery and/or conservative measures)
Not yet recruiting
- Sinusitis
- +10 more
- Treatment with surgery and/or conservative measures
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana
Sep 3, 2023
HIV Trial (Blood sample)
Not yet recruiting
- HIV Infections
- Blood sample
- (no location specified)
Aug 7, 2023
Cerebral Adrenoleukodystrophy (CALD) Trial in Worldwide (Lenti-D)
Active, not recruiting
- Cerebral Adrenoleukodystrophy (CALD)
- Lenti-D
-
Palo Alto, California
- +7 more
Mar 22, 2022
Clozapine-associated Infection
Completed
- Infections
- search for a clozapine intake
-
Caen, Normandie, FranceCaen University Hospital, Department of Pharmacology
Jun 23, 2023
Patients With Infection by Resistant Microorganism
Enrolling by invitation
- Pneumonia
- +10 more
- Pathogen resistant phenotype
-
Sevilla, SpainHospital Universitario Virgen Macarena
May 18, 2023
Short Versus Long Duration of Therapy for Streptococcus
Recruiting
- Streptococcus Pneumoniae
- pneumoniae bacteremia therapy
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Rectal Cancer, Organ-Space Surgical Site Infection Trial in Granollers (Person-level linkage of both databases looking for
Completed
- Rectal Cancer
- Organ-Space Surgical Site Infection
- Person-level linkage of both databases looking for concordance in the diagnosis of organ-space surgical site infection
-
Granollers, Barcelona, SpainHospital General de Granollers
Oct 30, 2023
Hemophilia A Trial in Milwaukee (Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human
Recruiting
- Hemophilia A
- Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Dec 21, 2022
Pediatric and Adult Liver Transplant Recipients in China
Not yet recruiting
- Cytomegalovirus (CMV) Infections Among Children and Adult Liver Transplantation Patients in China
- (no location specified)
Jul 21, 2023
Wiskott-Aldrich Syndrome Trial in Paris, London (Autologous CD34+ cells transduced with WASP lentiviral vector)
Active, not recruiting
- Wiskott-Aldrich Syndrome
- Autologous CD34+ cells transduced with WASP lentiviral vector
-
Paris, France
- +1 more
May 31, 2021
Chlamydia Trial in Kenya, United States (3-Day Regimen of Doxycycline, 7-Day Regimen of Doxycycline)
Not yet recruiting
- Chlamydia
- 3-Day Regimen of Doxycycline
- 7-Day Regimen of Doxycycline
-
Atlanta, Georgia
- +5 more
Apr 21, 2023